The Alliance for Multispecialty Research (AMR) is a unique network of integrated, geographically diverse, and highly experienced Clinical Research Centers of Excellence. Chartered as a formal organization in 1994, AMR Centers of Excellence provide clinical trial services across a broad base of therapeutic areas to the pharmaceutical, biotechnology, nutrition and medical device industries.
To learn more about AMR’s fully integrated network, click here:


Fibromyalgia Study

  • April 13, 2017

The purpose of this study is to evaluate the safety and effectiveness of an investigational medication for fibromyalgia as compared to a placebo.

Duration:  Approximately 12 weeks

Number of visits to CKRA:  7

Compensation:  Up to $525 for time and travel

NOTE:  Qualified participants must be between the ages of 18 and 80 years old, have had fibromyalgia for at least the past 3 months, and must not have any other disorders that would otherwise explain the pain.  Other criteria also apply.

Fibromyalgia Studies - Interest Form

If you are interested in joining the waiting list for upcoming fibromyalgia studies, please fill out the form below. This will help us determine if you meet some of the initial criteria necessary to participate. We will contact you when we conduct a fibromyalgia study that may be of interest to you. Per CKRA's privacy policy, all of your personal information that we have obtained will be kept in our secure database, which can only be accessed by authorized CKRA personnel, unless given your permission or except as required by law.
  • At least one phone number, either mobile or other, must be provided.